For citations:
Markova T.N., Stas M.S. The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus. Diabetes mellitus. 2024;27(2):174-184. (In Russ.) https://doi.org/10.14341/DM13106
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
